نتایج جستجو برای: year qaly algorithm

تعداد نتایج: 1337946  

2013
Montarat Thavorncharoensap Yot Teerawattananon Sirin Natanant Wantanee Kulpeng Jomkwan Yothasamut Pitsaphun Werayingyong

BACKGROUND This study aims to elicit the value of the willingness to pay (WTP) for a quality-adjusted life year (QALY) and to examine the factors associated with the WTP for a QALY (WTP/QALY) value under the Thai health care setting. METHODS A community-based survey was conducted among 1191 randomly selected respondents. Each respondent was interviewed face-to-face to elicit his/her health st...

Journal: :BMC Cardiovascular Disorders 2001
Tricia Nicholson Alistair McGuire Ruairidh Milne

BACKGROUND Low molecular weight heparins hold several advantages over unfractionated heparin including convenience of administration. Enoxaparin is one such heparin licensed in the UK for use in unstable coronary artery disease (unstable stable angina and non-Q wave myocardial infarction). In these patients, two large randomised controlled trials and their meta-analysis showed small benefits fo...

Journal: :Journal of diabetes science and technology 2011
Shihchen Kuo Cindy L Bryce Janice C Zgibor Donna L Wolf Mark S Roberts Kenneth J Smith

BACKGROUND Applying the chronic care model (CCM) for diabetes management helps improve health outcomes and patient care. The CCM was implemented at U.S. Air Force Wilford Hall Medical Center through the Diabetes Outreach Clinic (DOC) in 2006, but its cost-effectiveness in this setting is unknown. METHODS We constructed a Markov decision model to estimate DOC cost-effectiveness compared with u...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014
M Psenkova S Mackovicova D Tomek

• Threshold: λ1 = 24-multiple and λ2 = 35-multiple of average monthly wage valid 2 years before the year of submission. • In 2014: λ1 = 19,320 €/QALY, λ2 = 28,175 €/QALY. • Drugs with ICER between λ1 and λ2 or a prevalence below 1:100,000 are reimbursed conditionally, with claw-back. • Drugs with ICER above λ2 cannot be included in the Reimbursement list and can be reimbursed only at the exempt...

Journal: :Medical decision making : an international journal of the Society for Medical Decision Making 2016
Donna Rowen John Brazier Clara Mukuria Anju Keetharuth Arne Risa Hole Aki Tsuchiya Sophie Whyte Phil Shackley

OBJECTIVES . Recent proposals for value-based assessment, made by the National Institute of Health and Care Excellence (NICE) in the United Kingdom, recommended that burden of illness (BOI) should replace end of life (EOL) as a factor for consideration when deciding on new health technologies. This article reports on a study eliciting societal preferences for 1) BOI from a medical condition, de...

Journal: :Health economics 2011
Benjamin M Craig Jan J V Busschbach

By polling individual responses to hypothetical scenarios, valuation studies estimate population preferences toward health on a quality-adjusted life year (QALY) scale. The scenarios typically involve trade-offs in time (time trade-off (TTO)), risk (standard gamble (SG)), or number of persons affected (person trade-off (PTO)). This paper revisits the QALY assumptions and provides a coherent hea...

2014
Dilip Nathwani Oliver A. Cornely Anke K. Van Engen Olatunji Odufowora-Sita Peny Retsa Isaac A. O. Odeyemi

OBJECTIVES Fidaxomicin was non-inferior to vancomycin with respect to clinical cure rates in the treatment of Clostridium difficile infections (CDIs) in two Phase III trials, but was associated with significantly fewer recurrences than vancomycin. This economic analysis investigated the cost-effectiveness of fidaxomicin compared with vancomycin in patients with severe CDI and in patients with t...

2014
Yingyan Ma Xiaohua Ying Haidong Zou Xiaocheng Xu Haiyun Liu Lin Bai Xun Xu Xi Zhang Haotian Lin

BACKGROUND AND PURPOSE To evaluate the influence of rhegmatogenous retinal detachment (RRD) surgery on elderly patients in terms of visual acuity, vision-related quality of life and its cost-effectiveness. METHODS Elderly patients over 70 years old, who were diagnosed and underwent RRD surgery at Shanghai First People's Hospital, Shanghai Jiao Tong University, China, from January 1, 2009, thr...

Journal: :Journal of health economics 2012
Jeff Round

Recent research into end of life and palliative care has focused on the development of a replacement for the quality adjusted life year (QALY) as an outcome measure. Reasons given range from the lack of anticipated survival benefit from treatment to the inappropriateness of death as an anchor for valuing health states, or the increased value of time to the individual at the end of life. The Pal...

2017
Sek Hung Chau Reinier L. Sluiter Wietske Kievit Michel Wensing Martina Teichert Jacqueline G. Hugtenburg

PURPOSE The present study aimed to assess the cost effectiveness of concomitant proton pump inhibitor (PPI) treatment in low-dose acetylsalicylic acid (LDASA) users at risk of upper gastrointestinal (UGI) adverse effects as compared with no PPI co-medication with attention to the age-dependent influence of PPI-induced adverse effects. METHODS We used a Markov model to compare the strategy of ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید